Representative before the EPO

Employment test 11 - 50 employees
Company dna elkington and fife llp
operating since 1927
Headquarter in London and 3 offices
active in Legal Services and IP Consulting

We have observed 40 EP applications Richard Spencer Cooke has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11727744

PROCESSES FOR THE PREPARATION OF DIPYRIDAMOLE

IPC classification:
A61K 31/519, A61P 7/02, C07D 487/04
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Almut Susanne Elend, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP11726483

CRYSTALLINE FORMS OF THALIDOMIDE AND PROCESSES FOR THEIR PREPARATION

IPC classification:
A61K 31/454, A61P 29/00, A61P 37/00, C07D 401/04
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Matthew Bryce O'Neill, Generics (UK) Limited
Status:
EXAMINATION IN PROGRESS
EP11741276

PURE ERLOTINIB

IPC classification:
A61K 31/517, A61P 35/00, C07D 239/94
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Almut Susanne Elend, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP12187611

Hydrobenzamide derivatives as inhibitors of HSP90

IPC classification:
A61K 31/496, A61P 35/00, C07C 65/05, C07C 69/02, C07D 209/44
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP12174951

A Composition containing a Bisphosphonic Acid in combination with Vitamin D

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/593, A61K 31/663, A61P 19/08
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Stephen William Johnson, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP12731178

NOVEL PROCESS FOR THE PREPARATION OF ETRAVIRINE

IPC classification:
C07D 239/48
Agent:
Alexander Wittkopp, Maiwald Patentanwalts GmbH
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Alexander Wittkopp, Hamm & Wittkopp Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP11759968

SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS BETA-SECRETASE INHIBITORS

IPC classification:
A01N 43/52, A61K 31/415
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13171324

Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom

IPC classification:
C07C 237/10, C08F 20/34, C08F 20/60, C11D 3/37
Applicant:
Solvay USA Inc.
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12848416

MODULATORS OF OPIOID RECEPTORS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/437, A61P 29/00, A61P 35/00, C07D 403/04, C07D 471/04
Agent:
Jones Day
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP13765015

TRIS(HYDROXYMETHYL)AMINOMETHANE SALTS OF A SMALL-MOLECULE GLP1R AGONIST AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A01N 25/08
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP12880074

FENOFIBRATE FORMULATION

IPC classification:
A61K 9/14, A61P 3/06
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP12879875

FENOFIBRATE FORMULATION

IPC classification:
A61K 9/16
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13807852

IMIDAZO BICYCLIC IMMINIUM COMPOUNDS AS ANTITUMOR AGENTS

IPC classification:
A61K 31/4188, A61K 31/429, A61K 31/437, A61K 31/5383, A61K 31/55, A61P 35/00, C07D 471/04, C07D 487/04
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
PATENT GRANTED
EP13776676

TREATMENT OF MILD AND MODERATE ALZHEIMER'S DISEASE

IPC classification:
A61K 31/13, A61K 31/4164, A61P 3/10, A61P 25/20, A61P 25/28
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13855010

INDOLE COMPOUNDS AND THEIR USE AS ANTIMICROBIALS

IPC classification:
A61K 31/4178, A61P 31/04, C07D 401/14
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13860348

MEDICAMENT INFORMATION SYSTEM AND METHOD

IPC classification:
G08B 29/00
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13860009

MEDICAMENT STORAGE, DISPENSING, AND ADMINISTRATION SYSTEM AND METHOD

IPC classification:
A61J 1/03
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13830187

AN IMPROVED PROCESS FOR THE PREPARATION OF LINAGLIPTIN

IPC classification:
C07D 473/04
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Stephen William Johnson, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP15150813

Formulations, salts and polymorphs of transnorsertraline and uses thereof

IPC classification:
A61K 9/20, A61K 31/135, A61K 31/70, A61P 25/00
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12814094

LEVOTHYROXINE FORMULATION WITH ACACIA

IPC classification:
A61K 9/20, A61K 31/198, A61K 47/14
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Stephen William Johnson, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP14702159

COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS

IPC classification:
A61K 31/155, A61K 31/5383, A61P 3/10
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP14710738

SOLID COMPOSITIONS COMPRISING A GLUCOKINASE ACTIVATOR AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 31/426
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14765775

MANUFACTURING PROCESS FOR EFFERVESCENT DOSAGE FORMS

IPC classification:
A61K 47/30, A61K 47/38, A61K 47/48
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14747154

NOVEL POLYMORPH OF TENOFOVIR DISOPROXIL MALEATE

IPC classification:
A61K 31/675, A61P 31/18, A61P 31/20, C07F 9/6561
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Almut Susanne Elend, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP15174854

NEW THERAPEUTIC AGENTS

IPC classification:
A61K 31/4035, A61P 35/00, C07D 209/48, C07D 401/06, C07D 403/06
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP14757979

PROCESS FOR THE PREPARATION OF NEPAFENAC

IPC classification:
C07C 231/12, C07C 237/20, C07C 319/20
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Agent:
Stephen William Johnson, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP14784385

USE OF A PPAR-DELTA AGONIST FOR TREATING MUSCLE ATROPHY

IPC classification:
A61K 31/192, A61P 21/00
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP11714962

SOLID SILANES

IPC classification:
C09C 3/12
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
No opposition filed within time limit
EP14819079

AMORPHOUS COBICISTAT SOLID DISPERSION

IPC classification:
A61K 9/10, A61K 9/16, A61K 9/20, A61K 31/4178
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14827535

IMPROVED PROCESS FOR THE PREPARATION OF POMALIDOMIDE AND ITS PURIFICATION

IPC classification:
C07D 401/04
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14827866

PREPARATION OF COBICISTAT INTERMEDIATES

IPC classification:
C07D 203/24, C07D 295/26
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14835503

PROCESS FOR THE PREPARATION OF SOFOSBUVIR

IPC classification:
C07H 19/06
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP11745064

SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

IPC classification:
A01N 43/78, A61K 31/425, C07D 277/00, C07D 417/12
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP15710893

CRYSTALLINE FORMS OF DOLUTEGRAVIR SODIUM

IPC classification:
C07D 498/14
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15792097

METHODS AND COMPOSITIONS OF DASOTRALINE FOR TREATMENT OF ADHD

IPC classification:
A61J 3/07, A61K 31/03, C07C 211/42, C07C 211/45
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15792455

DOSAGE OF DASOTRALINE AND METHOD FOR TREATMENT OF ADHD

IPC classification:
A61K 31/137, A61K 31/165, C07C 211/42
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15770614

PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHBITION OF ERK5

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 413/12, C07D 413/14
Applicant:
Cancer Research Technology Ltd
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
Request for examination was made
EP15785186

COMPLEX OF AMORPHOUS EMPAGLIFLOZIN AND A CYCLODEXTRIN

IPC classification:
A61K 31/351, A61P 3/10, C07D 407/12
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
Request for examination was made
EP15861509

MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF

IPC classification:
A61K 31/435, C07D 215/56, C07D 401/06
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
Request for examination was made
EP16203981

DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

IPC classification:
A61K 31/423, A61K 31/573, A61K 45/06, A61P 21/00, C07D 263/58
Agent:
Richard Spencer Cooke, Elkington and Fife LLP
Status:
The application has been published

Please Sign in to use this feature